04.24.20

David Rostov Joins CorneaGen as Chief Financial Officer

Source: CorneaGen
CorneaGen announced that David Rostov has joined the company as chief financial officer. Mr. Rostov has more than 20 years of C-suite experience in scaling fast-growing technology companies, mergers and acquisitions and corporate fundraising, according to a company news release. His skills will be critical to CorneaGen’s success in innovating and leveraging the next generation of cornea care to eliminate corneal blindness worldwide, starting with Cornea Cell Therapy Transplantation.



“David rose to the top of a very competitive field of highly qualified candidates,” CorneaGen President and CEO Monty Montoya, said in a company news release. “His deep experience and leadership style are a great fit for CorneaGen’s culture and where we are headed in the future.”



Mr. Rostov recently served as CFO at Donuts Inc., a provider of services for digital identity management, where his efforts resulted in accelerated year-over-year growth with high EBITDA profitability and a successful sale to a private equity firm. Mr. Rostov also held the CFO role at Avalara, which offers a cloud-based software solution for transactional taxes, and at Infospace, a publicly traded internet services company. He was responsible for increased efficiency, certain key acquisitions and helped support dramatic annual revenue growth for both organizations. Mr. Rostov also was part of the management team that launched drugstore.com, helped grow the business and took the company public.



“I couldn’t be more excited to join CorneaGen and help lead them into the future of cornea care,” said Mr. Rostov. “I have deep ties to the mission and am passionate about helping that mission forward.”


Related Content